TGFB1 and glomerulosclerosis: Consistent with previous studies [38], we now show a correlative reduction in oxidative stress, and a reduction in the activity of the profibrotic cytokine, TGF-β, as well as reductions in tubulointerstitial fibrosis and glomerulosclerosis within the diabetic kidney through the use of Eb and its analogue.